Previous T cell receptor (TCR) sequence analysis of a panel of 23 H-2K d restricted cytotoxic T lymphocyte (CTL) clones recognizing the decapeptide HLA-CW3 170-179 revealed a striking conservation of TCR structure, in that all clones examined used V310 and Jcz pHDS58 segments. We show here that the primary response in vivo after intraperitoneal injection of DBA/2 mice with HLA-CW3 expressing transfectants of syngeneic P815 (H-2 d) tumor cells is characterized by a dramatic expansion of CD8 + V/810 + CTL in the peritoneal cavity and draining (mesenteric) lymph node, as well as in peripheral blood. Additional analysis of TCR on HLA-CW3 immune populations by flow cytometry and polymerase chain reaction further indicates that the vast majority of responding CD8 + cells express restricted Vc~ domains, a dominant Jc~ segment (pHDS58), and a conserved CDR3 length for both c~ and/8 chains. This novel system provides a unique opportunity to directly monitor an oligoclonal primary antigen specific immune response in vivo at the single cell level independently of functional assays.
T
he TCR-otl/8 on CD4 § and CD8 § T cells recognizes processed peptides bound to MHC class II or I molecules, respectively. TCR repertoire diversity is determined by the number of distinct gene segments encoding variable (V, D, and J) elements of the ot and/8 chains as well as by N-nucleotide additions that occur during somatic recombination. Although it is generally accepted that variable components of both TCR ot and/8 chains contribute to the specificity of recognition of a given peptide-MHC complex, there are many documented cases in which preferences for certain TCR gene elements occur (1) . A striking example of TCR preference concerns the recognition of the decapeptide HLA-CW3 170-179 in association with H-2K d. In this system, 23 independent CD8 ~ CTL dones were all found to use the V/810 domain and a unique Jo~ segment (2) . Furthermore, CD8 + peritoneal exudate lymphocytes (PEL) recovered from the site of secondary rejection of syngeneic tumor cell transfectants expressing HLA-CW3 were highly enriched in V310 + cells (2) . These findings prompted us to investigate whether the primary in vivo immune response to this peptide antigen could be followed directly by flow cytometric 1 The first two authors made equivalent contributions to this work.
analysis of CD8 § V/810 + cells. We show here that CD8 + V/810 § cells increase dramatically in the lymphoid tissues and blood of DBA/2 mice during the course of a primary immune response to syngeneic P815 tumor cells transfected with the HLA-CW3 gene. This novel system provides a powerful tool to investigate many quantitative aspects of antigen-specific in vivo immune responses independently of functional assays.
Materials and Methods
Immunization. Cytolytic Assay. P815-CW3 transfectants and control P815 tumor cells were labeled with StCr as described (3) . 2 x 103 SlCrlabeled target cells were mixed with varying numbers of sorted effector cells in V-bottomed microplates. S*Cr-release in supernatants was quantitated after 3.5 h.
cDNA-PCR and Direct Sequencing. RNA extraction, cDNA synthesis, and PCR using Vc~8, V310, Cc~, and C3 primers were carried out on CTL clones and freshly isolated PBL or PEL as previously described (2, 7) . Direct sequencing of the PCR products was as described (8) .
Results and Discussion
We have recently shown that a large panel of independent CD8 + CTL clones recognizing the peptide CW3 170-179 in association with H-2K a utilize exclusively the TCR VB10 domain (2) . This surprising result prompted us to examine the TCR V3 usage of CD8 + T cells during a primary response to this antigen in vivo. For this purpose, DBA/2 (H-2 d) mice were injected intraperitoneally with viable syngeneic P815 mastocytoma cells transfected with the HLA-CW3 gene. Previous studies have shown that such P815-CW3 transfectants are normally rejected by DBA/2 mice within 10-12 d and that CD8 + CTL clones specific for CW3 170-179 can be derived from such an immunization protocol (3, 9) .
As shown in Fig. 1 , PBL from DBA/2 mice taken 10 d after injection of 107 P815-CW3 transfectants contained a very high proportion (,'o65%) of CD8 + Vfll0 + cells, as compared with PBL from control mice (7% CD8 + V310+). This enrichment of V310 + cells occurred only in the CD8 + subset since CD4 § V310 § PBL from immune mice remained at the same level (,o10%) as in unimmunized controls. Analysis of various tissues at day 10 after immunization further indicated that CD8 + Vfll0 § cells were specifically elevated not only in blood but also in the peritoneal cavity, spleen, and draining (mesenteric) lymph node ( Table 1 ). In contrast, no increase in CD8 § VBI0 + cells was seen in distant (ei- ther axillary or inguinal) lymph nodes (Table 1) . Kinetic studies (Fig. 2 ) demonstrated that increases in CD8 + VB10 + cells first could be detected in blood after 6 d and persisted at high levels for at least 5 wk after immunization.
To further define the correlation between expression of V~10 and specificity for HLA-CW3 in vivo, CD8 + PEL or PBL from DBA/2 mice that had rejected P815-CW3 transfectants were sorted on the basis of V~10 expression (Fig. 1 ) and subsequently tested for cytolytic activity on P815-CW3 or con- trol P815 target cells. As shown in Fig. 3 , HLA-CW3 specific CTL activity was only detected in the CD8 + VB10 + populations, indicating that few (if any) VB10-specific CTL were generated during the immunization procedure. This finding demonstrates dearly that the unique VBIO expression observed among 23 CTL clones characterized in our previous study (2) gene family and 4 of 23 clones used a particular Vot8 gene segment (p71). We therefore stained P815-CW3 immune PEL or PBL with mAbs B21.14 (4) or KT50 (5), both of which recognize Vot8-expressing T ceils. Approximately 15% of CD8 + VB10 + cells from day 12 immune mice were stained with either of these mAbs, as compared with 3-4% in control DBA/2 mice (Fig. 4 and data not shown). In contrast, Vot2 expression was much lower among day 12 immune CD8 + VB10 + ceils than in normal DBA/2 controls (Fig.  4 and data not shown). These data emphasize the restricted Vot repertoire of P815-CW3 reactive CD8 + T cells and again concur with previous estimates of Vot usage in our panel of CTL clones. In addition to V domain preferences, other structural features of the TCR were highly conserved in our panel of HLA-CW3 specific CTL clones. In particular, all clones examined used theJc~ pHDS58 segment and both ot and/3 chains showed a highly conserved length of the CDR3 domain (2). To determine whether such features also applied to the TCR of CD8 + cells generated in a primary response in vivo to PS15-CW3 transfectants, we performed direct sequencing of PCR amplified cDNA obtained from immune PBL and PEL populations.
To examine directly the B chain junctional region, a combination of V~10 and C~/primers was used to amplify cDNA from day 10 PBL and PEL. The PCR products were directly sequenced with a second antisense CB primer located close to the VDJCjunction (Fig. 5 A) . As expected, the sequencing reaction was essentially unreadable through the junctional region (with the exception of two successive guanine nucleotides encoding a conserved glycine residue at position 97). However, the sequence of VB10 was clearly readable, indicating that most Vfll0-bearing cDNAs from the immune PBL or PEL populations had the same junctional length encoding six amino acids in the CDR3 loop. This nucleotide structure is identical to that found in fl chains of CTL clones reactive with HLA-CW3 (2 and Fig. 5 A) . The sequence of Vfll0-Cfl PCR products obtained from control unimmunized DBA/2 PBL was not readable in either the junctional or VfllO region (Fig. 5 A) .
To analyze the TCR c~ chain structure of day 10 immune PBL or PEL, a combination of Vot8 and Cot primers was used. Sequencing of the PCR products was performed with a second Cot primer located close to the VJC junction (Fig.  5 B) . Remarkably, the Jot pHDS58 sequence was clearly readable in the day 10 PEL and, to a lesser extent, PBL populations. Furthermore, after a short unreadable stretch corresponding to the VJ junction, the Vot8 sequence was also readable. These data demonstrate that most VotS-bearing cDNAs in the immune PBL or PEL populations have a conserved CDR3 loop of nine amino acids incorporating the Jot pHDS58 sequence. Again, this nucleotide structure is identical to that found in Vcc8-bearing HLA-CW3 specific CTL clones (2 and Fig, 5 B) . No readable sequence was obtained when the same Vot8 and Cot primers were used to amplify cDNA for unimmunized DBA/2 PBL (Fig. 5 B) . Taken together, the results indicate that the primary CD8 + T cell response to HLA-CW3 transfectants in vivo is highly oligoclonal and that the TCR structure of most responding cells is identical to that described previously for established CTL clones with the same antigen specificity.
The observed increases in CD8 + VfllO + cells after immunization with P815-CW3 transfectants are even more striking when expressed in terms of absolute cell numbers. As illus- (11, 12) .
The sustained increase in oligoclonal CD8 + VB10 + cells observed here during the primary response to HLA-CW3 transfectants is in marked contrast to recent studies of the T cell response in vivo to bacterial or retroviral superantigens. In the latter case, a limited proliferation of polyclonal VB" restricted superantigen-reactive T cells occurs, but this initial expansion phase is followed by the death of the majority of the reactive T cells in both CD4 + and CD8 + subsets (13) (14) (15) . It will be of considerable interest to compare other physiological parameters of VB-restricted T cells involved in primary responses to peptide antigens and superantigens.
To our knowledge, the data documented in this report represent the first instance in which it has been possible to directly quantitate a primary peptide antigen specific T cell response in vivo at the single cell level independently of functional assays. This unique model system should allow a detailed analysis of the cellular requirements of such a response, as well as new insights into poorly understood areas such as T cell activation, recirculation, and memory.
